Pathology and biology of radiation-induced cardiac disease - PubMed (original) (raw)
Review
. 2016 Sep;57(5):439-448.
doi: 10.1093/jrr/rrw064. Epub 2016 Jul 15.
Affiliations
- PMID: 27422929
- PMCID: PMC5045085
- DOI: 10.1093/jrr/rrw064
Review
Pathology and biology of radiation-induced cardiac disease
Soile Tapio. J Radiat Res. 2016 Sep.
Abstract
Heart disease is the leading global cause of death. The risk for this disease is significantly increased in populations exposed to ionizing radiation, but the mechanisms are not fully elucidated yet. This review aims to gather and discuss the latest data about pathological and biological consequences in the radiation-exposed heart in a comprehensive manner. A better understanding of the molecular and cellular mechanisms underlying radiation-induced damage in heart tissue and cardiac vasculature will provide novel targets for therapeutic interventions. These may be valuable for individuals clinically or occupationally exposed to varying doses of ionizing radiation.
Keywords: cardiac disease; endothelial cell; heart; ionizing radiation; myocardium.
© The Author 2016. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.
Figures
Fig. 1.
Proposed model of the biological pathways in cardiomyocytes, smooth muscle cells (SMCs) and endothelial cells involved in radiation-induced heart disease. In cardiomyocytes, the inactivation of PPAR alpha, reduced fatty acid oxidation (FAO), increased inflammatory response, and enhanced production of mitochondrial ROS are indicated. In SMCs, the adverse effects on paxillin/integrin and actin signaling, cytoskeletal organization, and cell–cell junctions are shown. In endothelial cells, the inactivation of PI3K, MAP kinase and Rho signaling pathways, increased cytoskeletal disorganization, decreased NO production and bioavailability, and enhanced leukocyte migration due to increased cell adhesion and loosening of cell–cell junctions are indicated.
Similar articles
- [Cardiotoxic consequences of ionizing radiation and anthracyclines].
Przybyszewski WM, Wideł M, Rzeszowska-Wolny J. Przybyszewski WM, et al. Postepy Hig Med Dosw (Online). 2006;60:397-405. Postepy Hig Med Dosw (Online). 2006. PMID: 16921339 Review. Polish. - Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury.
Slezak J, Kura B, Babal P, Barancik M, Ferko M, Frimmel K, Kalocayova B, Kukreja RC, Lazou A, Mezesova L, Okruhlicova L, Ravingerova T, Singal PK, Szeiffova Bacova B, Viczenczova C, Vrbjar N, Tribulova N. Slezak J, et al. Can J Physiol Pharmacol. 2017 Oct;95(10):1190-1203. doi: 10.1139/cjpp-2017-0121. Epub 2017 Jul 27. Can J Physiol Pharmacol. 2017. PMID: 28750189 Review. - Long-term cellular effects in humans chronically exposed to ionizing radiation.
Veremeyeva G, Akushevich I, Pochukhailova T, Blinova E, Varfolomeyeva T, Ploshchanskaya O, Khudyakova O, Vozilova A, Kozionova O, Akleyev A. Veremeyeva G, et al. Health Phys. 2010 Sep;99(3):337-46. doi: 10.1097/HP.0b013e3181d11303. Health Phys. 2010. PMID: 20699695 - Understanding radiation-induced cardiovascular damage and strategies for intervention.
Stewart FA, Seemann I, Hoving S, Russell NS. Stewart FA, et al. Clin Oncol (R Coll Radiol). 2013 Oct;25(10):617-24. doi: 10.1016/j.clon.2013.06.012. Epub 2013 Jul 20. Clin Oncol (R Coll Radiol). 2013. PMID: 23876528 Review. - Responses of normal cells to ionizing radiation.
Rodemann HP, Blaese MA. Rodemann HP, et al. Semin Radiat Oncol. 2007 Apr;17(2):81-8. doi: 10.1016/j.semradonc.2006.11.005. Semin Radiat Oncol. 2007. PMID: 17395038 Review.
Cited by
- Cohort Studies and Multi-omics Approaches to Low-Dose Ionizing Radiation-Induced Cardiovascular Disease: A Comprehensive Review.
Zong X, Zhu L, Wang Y, Wang J, Gu Y, Liu Q. Zong X, et al. Cardiovasc Toxicol. 2024 Nov 13. doi: 10.1007/s12012-024-09943-5. Online ahead of print. Cardiovasc Toxicol. 2024. PMID: 39538046 Review. - The potential treatment of N-acetylcysteine as an antioxidant in the radiation-induced heart disease.
Li YL, Wang G, Wang BW, Li YH, Ma YX, Huang Y, Yan WT, Xie P. Li YL, et al. Cardiovasc Diagn Ther. 2024 Aug 31;14(4):509-524. doi: 10.21037/cdt-24-19. Epub 2024 Aug 21. Cardiovasc Diagn Ther. 2024. PMID: 39263473 Free PMC article. - Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight.
Morris PD, Anderton RA, Marshall-Goebel K, Britton JK, Lee SMC, Smith NP, van de Vosse FN, Ong KM, Newman TA, Taylor DJ, Chico T, Gunn JP, Narracott AJ, Hose DR, Halliday I. Morris PD, et al. Nat Rev Cardiol. 2024 Oct;21(10):667-681. doi: 10.1038/s41569-024-01047-5. Epub 2024 Jul 19. Nat Rev Cardiol. 2024. PMID: 39030270 Review. - Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients.
Cronin M, Lowery A, McInerney V, Wijns W, Kerin M, Keane M, Blazkova S, Neiuroukh D, Martin M, Soliman O. Cronin M, et al. Breast Cancer Res Treat. 2024 Sep;207(2):283-291. doi: 10.1007/s10549-024-07322-w. Epub 2024 Jun 26. Breast Cancer Res Treat. 2024. PMID: 38922547 Free PMC article. - Dexmedetomidine ameliorates x-ray-induced myocardial injury via alleviating cardiomyocyte apoptosis and autophagy.
Zhang R, Xie K, Lian Y, Hong S, Zhu Y. Zhang R, et al. BMC Cardiovasc Disord. 2024 Jun 26;24(1):323. doi: 10.1186/s12872-024-03988-8. BMC Cardiovasc Disord. 2024. PMID: 38918713 Free PMC article.
References
- Rosamond W, Flegal K, Friday G, et al. .. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69–171. - PubMed
- Cannon B. Cardiovascular disease: biochemistry to behaviour. Nature 2013;493:S2–3. - PubMed
- Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003;46:11–29. - PubMed
- Wilson PW, D'Agostino RB, Levy D, et al. .. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–47. - PubMed
- Adams J, Palombella VJ, Elliott PJ.. Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs 2000;18:109–21. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical